Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artesunate-amodiaquine and artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in young children in Equatorial Guinea
ACTRN12617000456358Phase 4Completed
- Sponsor
- Ministry of Health and Social Welfare of Equatorial Guinea
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of artesunate, amodiaquine, artemether and lumefantrine in malaria and Malaria (2 arms), sponsored by Ministry of Health and Social Welfare of Equatorial Guinea. Primary endpoints: Treatment failure rate, Adequate clinical and parasitological response and 2 more. Started Aug 2017; status: completed.
02
Drugs
artesunateamodiaquineartemetherlumefantrine
03
Conditions
malariaMalaria
Beyond the preview
Go deeper on ACTRN12617000456358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617000456358.